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S252 Poster Session Ichildren and adolescents with FA who underwent allogeneic HSCT
in a single institution.
Methodology: Pts were evaluated before and 180 days after HSCT.
We evaluated the lean mass (LM) by electrical bioimpedance, nutri-
tional status by anthropometric measurements, the food intake by
a 24 hours recall, the BMD by DXA (HOLOGIC-1000) and the se-
rum 25-hydroxyvitamin D (25-OHD).
Results: Between 08/2006 and 09/2008, twenty-four patients
were included in the study. Seven pts (29%) died before
D + 180 and were excluded from this analysis. 17 pts were able
to complete this survey. The median age at admission to the
BMT Unit was 8,5ys (5-16ys), 9 pts (53%) were female and 10
pts (59%) received TCTH from unrelated donors. Most patients
(88%) developed mucositis while 7 pts (41%) developed acute or
chronic graft-versus-host disease (GVHD). Prior to HSCT, 6 pa-
tients (35%) had moderate to severe malnutrition, 10 (59%) pre-
sented short stature, 2 (12%) had low BMD for age and 11
(65%) had low vitamin D serum levels. The energy consumption
was inadequate in 6 (35%) patients and no patient had inade-
quate protein intake. At 180 days post-HSCT, six (35%) patients
had inadequate caloric intake, 1 (5%) patient had inadequate pro-
tein intake and 13 patients (76%) had low vitamin D serum
levels. A severe weight loss (greater than 5%) occurred in 6
(35%) pts, the LM decreased in 8 (47%) patients and 10
(69%) had a reduction in BMD.
Conclusion: The prevalence of weight, LM and BMD reduction
was high after six months of HSCT. The vitamin D serum levels
were low before and after HSCT. Pre-transplant nutritional care
and nutritional status monitoring of these patients are essential to
ensure proper growth and development, reducing at the most as pos-
sible the nutritional deficit during treatment.253
LONG-TERM IMPACT OF HEMATOPOIETIC STEM CELL TRANSPLANTA-
TION ON THE NUTRITIONAL STATUS OF INFANTS
Koerich, A., Campos, D.J., Jung, R.M., Ordonez, A.M., Fortier, S.C.,
Koliski, A., Zanis Neto, J., Bonfim, C.M.S. Federal University of Parana,
Curitiba, PR, Brazil
Introduction:During the first 2 years of life the adequate nutritional
status (NS)maintenance is crucial to ensure full growth and develop-
ment.
Objectives:Evaluate changes inNS of infants undergoingHSCT in
Curitiba-Brazil during hospitalization and the long-term impact in
the NS. Analyze the nutritional therapy applied and implications
of this intervention to the patient’s outcome.
Methods: Data was collected retrospectively from medical records
considering the anthropometry at the time of hospitalization and
last outpatient visit. All pts younger than 2 years-old, transplanted
between 12/1990 and 11/2007 were included.
Results: 53pts were included, 38 (72%) were male, age was
13.56 6.2 months, 43 pts (81%) had non malignant diseases,
29 (55%) received HSCT from unrelated donors. At hospitaliza-
tion 17 pts (32%) showed mild to moderate malnutrition and 8
pts (15%) severe malnutrition. At hospital discharge, 21 pts
(40%) showed mild to moderate malnutrition and 9 pts (17%)
severe malnutrition. During hospitalization 6 pts (11%) lost 5-
10% of body weight and 3 pts (6%) lost over 10%. There was
no relationship between the baseline NS and survival, and be-
tween pathology, length of hospital stay and weight loss. 14
pts (26%) received tube feeding (TF) for 12.76 11.5 days, to
supply an average of 30.4 kcal/kg/day and 0.9 g protein/kg/day.
22 (42%) patients received parenteral nutrition (PN) for
15.76 6.1 days to supply 49.8 kcal/kg/day and 1.5 g protein/kg/
day. There was no statistical difference in the incidence of vom-
iting, diarrhea and hyperglycemia among patients who received
TF, PN or exclusively oral feeding. 30 pts survived at least
one year with a median follow up of 25406 1448 days. Age
was 6.46 3.9 years at the latest evaluation, 11 pts (33%) devel-
oped GVHD. Regarding the current NS, 19 pts (58%) had short
stature, 13 pts (39%) showed mild to moderate malnutrition and
4 pts (12%) had severe malnutrition. Analyzing the height/agecurve, 15 pts (45%) did not reach an ascendant growth curve af-
ter HSCT and 14 pts (42%) did not reach an ascendant weight/
age curve.
Conclusion:Weobserved a high prevalence ofmalnutrition prior to
HSCT and many pts persisted with long term deficits in height and
weight after transplant. The use of TF did not lead to increased gas-
trointestinal complications and could be used in order to prevent
weight loss during HSCT and diminish nutritional long term com-
plications.254
TWO YEARS WORKING: EXPERIENCE OF THE FIRST EXCLUSIVELY PEDI-
ATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PROGRAM IN COLOM-
BIA, SOUTHAMERICA
Estupinan, M., Chaparro, M. Fundacion Hospital de la Misericordia,
Bogota, Colombia
We describe the experience after two years working at the first ex-
clusively Pediatric Hematopoietic Stem cell Facility in Bogota, Co-
lombia. 26 hematopoietic stem cell transplants (HSCT) have been
done in our program. 15 (57%) allogeneic and 11(43%) autologous
HSCTs. Between allogeneic transplants all donors have been match
related donors, 53% of allogeneic transplants because acute leuke-
mia and 47% congenital or acquired bone marrow failure. Between
autologous transplants 11 patients, 6 high risk neuroblastoma (55%),
RelapsedHodgkin disease (18%), AML (9%), PNET (9%) andNon
Hodgkin lymphoma (9%). Primary results after two years are care-
fully described. Transplant related mortality is 11.5%, overall sur-
vival and event free survival are 50% and 50% respectively in
a follow up of one year. We conclude that in a pediatric population
is usual have more allogeneic transplants because of non malignant
diseases, the primary results are comparable with those for long
term experience centers given that the isolation rooms, pediatric fa-
cilities, Pediatric Intensive care in situ, and the well designed sup-
portive care strategies.255
THE IMPACT OF ROUTINE RANGE OF MOTION ASSESSMENT ON THE
EARLY IDENTIFICATION OF GRAFT VERSUS HOST DISEASE IN ALLOGE-
NEIC BONE MARROW TRANSPLANT RECIPIENTS
Hente, M.1, Chadakhtzian, A.1, Witte, B.1, Yocco, M.1, Hayashi, R.2,
Shenoy, S.2, Westfall, A.1 1St. Louis Children’s Hospital, St. Louis,
MO; 2Washington University, St. Louis, MO
Purpose:To explore the relationship betweenmonthly range ofmo-
tion assessment in allogeneic bone marrow transplant (BMT) recip-
ients and how it impacts early identification of graft versus host
disease (GvHD) and improved functional outcomes for this popula-
tion.
Abstract: Acute and chronic GvHD is prevalent in allogeneic BMT
recipients and can lead to debilitating skin and joint issues affecting
quality of life and mobility. As standard of care, these recipients re-
ceive Occupational and Physical Therapy services to combat or pre-
vent sequelae from this debilitating disorder. A recent review of
GvHD and Physical Therapy literature illustrates a lack of early
identification/prediction methods for this disorder. Very few studies
describe specific therapeutic interventions as prophylaxis utilizing
the expertise of Occupational and Physical Therapy personnel.
This institution hopes to change that and devise a method of useful
follow up.
The study population includes allogeneic BMT recipients ages
zero to 18 years old. The control group consists of the past 20 allo-
geneic bone marrow recipients and the experimental group includes
the next 20. Standard goniometry will be the assessment tool utilized
for passive range ofmotion. A baselinemeasurement will be obtained
during transplant admission, once a month for the next six months,
followed by every two to three months from month six to 24 on all
participants in the experimental group. The control group will re-
ceive standard goniometry assessment upon the diagnosis of any
GvHD, and/or at one year post transplant or with their next visit if
past one year. Functional outcomes will be measured using theWee-
FIM, which is an 18-item assessment of what a child actually does.
